tradingkey.logo
搜尋

Bio-Techne Corp

TECH
添加自選
72.270USD
+0.150+0.21%
收盤 09-11 16:00美東
11.28B總市值
102.42本益比TTM
盤後交易 16:07 (美東)72.320USD+0.050+0.07%

關於 Bio-Techne Corp 公司

Bio-Techne Corporation develop, manufacture and sell life science reagents, instruments and services for the research, diagnostics and bioprocessing markets worldwide. The Company’s segments include Protein Sciences segment and Diagnostics and Spatial Biology segment. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, advanced tissue-based in-situ hybridization assays and instrumentation for spatial genomic and tissue biopsy analysis and genetic and oncology kits for research and clinical applications. Its product portfolio and application enable scientific investigations into biological processes and molecular diagnostics and progression of specific diseases.

Bio-Techne Corp 簡介

公司代碼TECH
公司名稱Bio-Techne Corp
上市日期Feb 09, 1989
CEOKelderman (Kim)
員工數量3100
證券類型Ordinary Share
年結日Feb 09
公司地址614 Mckinley Pl N E
城市MINNEAPOLIS
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編55413
電話16123798854
網址https://www.bio-techne.com/
公司代碼TECH
上市日期Feb 09, 1989
CEOKelderman (Kim)

Bio-Techne Corp公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Kim Kelderman
Mr. Kim Kelderman
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
104.23K
+30.82%
Mr. Kim Kelderman
Mr. Kim Kelderman
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
104.23K
+30.82%
Mr. John L. Higgins
Mr. John L. Higgins
Independent Director
Independent Director
66.88K
--
Mr. John L. Higgins
Mr. John L. Higgins
Independent Director
Independent Director
66.88K
--
Mr. Robert V. (Bob) Baumgartner, CPA
Mr. Robert V. (Bob) Baumgartner, CPA
Independent Chairman of the Board
Independent Chairman of the Board
46.50K
--
Mr. Robert V. (Bob) Baumgartner, CPA
Mr. Robert V. (Bob) Baumgartner, CPA
Independent Chairman of the Board
Independent Chairman of the Board
46.50K
--
Dr. Joseph D. (Joe) Keegan, Ph.D.
Dr. Joseph D. (Joe) Keegan, Ph.D.
Independent Director
Independent Director
15.41K
--
Dr. Joseph D. (Joe) Keegan, Ph.D.
Dr. Joseph D. (Joe) Keegan, Ph.D.
Independent Director
Independent Director
15.41K
--
Mr. Shane Bohnen
Mr. Shane Bohnen
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
14.71K
+50.02%
Mr. Shane Bohnen
Mr. Shane Bohnen
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
14.71K
+50.02%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Kim Kelderman
Mr. Kim Kelderman
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
104.23K
+30.82%
Mr. Kim Kelderman
Mr. Kim Kelderman
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
104.23K
+30.82%
Mr. John L. Higgins
Mr. John L. Higgins
Independent Director
Independent Director
66.88K
--
Mr. John L. Higgins
Mr. John L. Higgins
Independent Director
Independent Director
66.88K
--
Mr. Robert V. (Bob) Baumgartner, CPA
Mr. Robert V. (Bob) Baumgartner, CPA
Independent Chairman of the Board
Independent Chairman of the Board
46.50K
--
Mr. Robert V. (Bob) Baumgartner, CPA
Mr. Robert V. (Bob) Baumgartner, CPA
Independent Chairman of the Board
Independent Chairman of the Board
46.50K
--

常見問題

Bio-Techne Corp的前五大股東是誰?

Bio-Techne Corp的前五大股東如下:Mr. Kim Kelderman

有多少機構持有Bio-Techne Corp(TECH)的股份?

截至2026Q1,共有1247家機構持有Bio-Techne Corp的股份,合計持有的股份價值約為178.19M,占公司總股份的113.81% 。與2025Q4相比,機構持股有所增加,增幅為1433.00。

哪個業務部門對Bio-Techne Corp的收入貢獻最大?

在2026Q1,Consumables業務部門對Bio-Techne Corp的收入貢獻最大,創收985.12M,占總收入的81.08% 。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有